Kyntra Bio, Inc. (KYNB)
7.39
+0.31
(+4.38%)
USD |
NASDAQ |
Apr 14, 16:00
7.39
0.00 (0.00%)
After-Hours: 20:00
Kyntra Bio Total Assets (Quarterly) : 119.59M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Anixa Biosciences, Inc. | 15.23M |
| GT Biopharma, Inc. | 8.106M |
| Gossamer Bio, Inc. | 172.25M |
| Monte Rosa Therapeutics, Inc. | 448.66M |
| Septerna, Inc. | 601.98M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 115.12M |
| Shareholders Equity (Quarterly) | -30.04M |
| Debt to Equity Ratio | -0.6512 |
| Current Ratio | 3.388 |
| Net Debt Paydown Yield | 41.38% |